Cite
HARVARD Citation
Akizawa, T. et al. (2014). Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study (Co‐JET study). Therapeutic apheresis and dialysis. 18 (2), pp. 140-148. [Online].